FLT3 and acute myeloid leukemia: Among mutational changes in the FLT3 gene, the most common are internal tandem duplications (ITD) detected in the juxtamembrane domain of the FLT3 gene, and they account for 25–30% of all AML cases, which often correlates with resistance to treatment and an unfavorable prognosis of the disease [7].